WEBINAR

Accelerating Peptide Development: Strategies to optimize the formulation and manufacture of peptide therapeutics

Register here

Integrated first-in-human and clinical pharmacology programs

Clinical Pharmacology

When you are looking for a partner who is dedicated to Phase I trials and early development, rely on Quotient Sciences. We accelerate your molecule from first-in-human to proof-of-concept, helping you make critical decisions earlier. Whatever clinical pharmacology study you require, you can expect a fully integrated program from study design to data reporting.

Employee at Quotient Sciences explaining the process of clinical trials to a volunteer

Experience and study types

  • Proven track record spanning 30 years
  • More than 1,300 Phase I studies completed
  • Experts in first-in-human (FIH) studies
  • Industry leading Phase I medical directors
  • Ability to rapidly recruit large groups of volunteers
  • Fully integrated programs led by experienced project managers
  • In-house data sciences team

Dedicated to your Phase I study

  • Purpose-built Phase I units in U.S. and U.K.
  • 229 beds globally
  • Experienced team of 16 physicians and principal investigators
  • Database of more than 25,000 healthy volunteers 
  • MHRA- and FDA-inspected facilities
  • Industry-leading U.S. IRB and U.K. CTA approval timelines

Project management

Your dedicated early phase project manager will provide you with customized service and 3rd party management/oversight. We deliver full-service programs on time, within budget and to the highest quality to meet your rigorous requirements and those of the regulatory agencies. For more information about Quotient Project Management, click here.

Benefit from dedicated study resources

Quotient has the experience and expertise to seamlessly deliver your studies with the highest quality service and speed. If you need a fully integrated solution including data management, data analysis, statistics and medical writing, Quotient is your answer.
  • Clinical pharmacology expertise including FIH (SAD/MAD), DDI, food effect and ADME experience
  • Experienced project managers guiding your study to successful on-time delivery, within budget and to the highest quality
  • On-site pharmacy compounding and integrated real-time adaptive GMP manufacturing
  • Formulation development for all dosage forms including oral solutions and suspensions, capsules and tablets, sterile preparations (IV and SC), inhaled and nasal devices, topical creams and gels
  • Early phase data sciences group providing full-service data management, statistics and medical writing
  • Regulatory support to ensure a seamless FDA or MHRA submission and approval process for clinical trial applications

Special populations

  • Healthy participants
  • Ages 65 and older
  • Post-menopausal
  • Male and female infertility
  • Hypertensive
  • Type II diabetics
  • Asthma
  • Allergic rhinitis 
  • Obese
  • Healthy smokers
  • Gastrointestinal diseases
  • Japanese

Quotient's Clinical

Pharmacology Facilities

Nottingham, UK

  • Over 650 Phase I studies completed
  • clinical unit with a dedicated 14C ADME ward & Lab

  • On-site pharmaceutical laboratories and GMP manufacturing

  • 9,000 active healthy volunteers in our database

  • 45 Phase I CTA submissions annually (more than any UK unit)

Miami, USA

  • Over 650 Phase I clinical studies completed

  • 144-bed clinical unit with dedicated FIH wards

  • On-site pharmacy, with clean rooms for aseptic products 

  • 19,000 active healthy volunteers in our database

  • Recruitment for special subject populations

Quotient Sciences Miami Facility

Ready to get started?
Connect With Quotient Today
We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.